Evidence map›Paper›PMID 41052219›Full record

ArticlePLoS pathogens2025

The serine protease HtrA regulates Group B Streptococcus virulence and affects the host response to infection.

Alyssa Brokaw, Grace Wallen, Austyn Orvis, Hei Joon Kwon, Ravin Seepersaud, Shayla Nguyen, Kavita Sharma, Michelle Coleman, Phoenicia Quach, Joy Twentyman and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Influenza A Virus Coinfection AltersbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alyssa BrokawCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Grace WallenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Austyn OrvisCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Hei Joon KwonCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Ravin SeepersaudCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Shayla NguyenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Kavita SharmaCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Michelle ColemanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Phoenicia QuachCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Joy TwentymanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Jay VornhagenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Lisa A JonesProteomics & Metabolomics Shared Resource, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Chenwei LinProteomics & Metabolomics Shared Resource, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Philip R GafkenProteomics & Metabolomics Shared Resource, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Lakshmi RajagopalCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0003-3373-2323

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Role of the hyaluronidase in GBS VirulenceR01AI133976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2017 to 2021
$4.5M
Immune Control of Group B Streptococcal PlacentalR01AI145890 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2019 to 2023
$4.4M
Neutralizing the GBS hemolytic lipid toxinR01AI167421 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2022 to 2025
$4.1M
FXIIIA production by mast cells for innate immunityR01AI152268 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI PILIPONSKY, ADRIAN M, RAJAGOPAL, LAKSHMI · 2020 to 2024
$3.7M
Role of an ornithine rhamnolipid pigment in GBS virulenceR01AI112619 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2018
$2.4M
NCI NIH HHS P30 CA015704NIAID NIH HHS R01 AI112619NIAID NIH HHS R01 AI133976NIAID NIH HHS R01 AI145890NIAID NIH HHS R01 AI152268NIAID NIH HHS R01 AI167421NIAID NIH HHS T32 AI007509
6 · The paper itself

Abstract

Group B Streptococcus (GBS) rectovaginally colonizes up to 20% of women worldwide and is a leading cause of invasive infections during pregnancy, contributing annually to a significant proportion of preterm births, neonatal infections, and stillbirths. Despite its reputation as a perinatal pathogen, GBS infection rates in non-pregnant adults are also increasing. While much progress has been made to understand transcriptional regulation of virulence by two-component systems, many aspects of GBS virulence regulation remain understudied. Although many bacterial pathogens utilize high temperature response A (HtrA) family serine proteases to regulate virulence and stress responses through varied mechanisms, the function of HtrA in GBS was unknown. Here, we demonstrate that HtrA is localized to the GBS membrane and regulates the abundance of endogenous surface and secreted proteins, including a subset of virulence factors. Although deletion of htrA (ΔhtrA) increased dissemination to placentas and fetuses, this strain caused significantly fewer adverse pregnancy outcomes compared to isogenic wild-type (WT). Placentas from ΔhtrA-infected dams contained more chemokines, pro-inflammatory IL-1β, and neutrophil myeloperoxidase than isogenic WT-infected placentas, suggesting that ΔhtrA GBS induces potent neutrophil chemotaxis. However, immunosuppressive IL-10 was present at increased concentration, which may in part explain the attenuation of adverse pregnancy outcomes during ΔhtrA infection. Finally, we note that recombinant GBS HtrA directly cleaves human fibronectin in vitro, highlighting that this protease may also target host substrates during infection. Together, these findings support a role for HtrA as a post-translational regulator of GBS virulence and suggest that inhibiting HtrA activity may hold therapeutic promise against GBS induced adverse pregnancy outcomes.

Indexed as

Bacterial ProteinsHigh-Temperature Requirement A Serine Peptidase 1Pregnancy Complications, InfectiousStreptococcal InfectionsStreptococcus agalactiaeAnimalsFemaleHumansMicePregnancyVirulenceVirulence FactorsBacterial ProteinsHigh-Temperature Requirement A Serine Peptidase 1Virulence Factors

Identifiers

PMID41052219
PMCPMC12520345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.